Peptide inhibitors recognize prefusion viral fusion proteins with heterogeneous stoichiometry and rapid kinetics
- 1The University of Texas at Tyler Health Science Center
Abstract
Peptide fusion inhibitors, an important class of antivirals, block viral entry by targeting fusion proteins required for membrane fusion. However, their interactions with intact trimeric fusion proteins remain elusive; direct observation of binding on virions or native-like trimers has been lacking. Here, we developed a single-molecule imaging platform to visualize peptide binding in real time. LP-98 bound HIV-1 Envelope (Env) trimers on virions and, unexpectedly, prefusion-stabilized soluble Env trimers, with higher affinity for virion-associated Env and, among soluble trimers, a mutant Env. RSV fusion-inhibiting T-118 and 4ca similarly engaged prefusion-stabilized fusion (F) trimers with rapid kinetics and high-nanomolar affinities. Binding to prefusion Env or F demonstrates that peptide inhibitors can act earlier than the canonical prehairpin-intermediate model suggests. Individual binding events revealed heterogeneous peptide-to-trimer stoichiometries, with single-peptide occupancy predominating, while stepwise and simultaneous events revealed multiple routes to higher occupancy. These findings expand the canonical model of peptide fusion inhibition and provide previously inaccessible mechanistic insights into how antiviral peptide fusion inhibitors act.
Related
- Investigating the anticancer potential of phytochemicals from the mangrove Rhizophora mucronata as inhibitors of lung cancer-associated proteins: Insights from multiscale computational and in silico analyses
- Genetically restricted human antibodies recognize a conserved β-hairpin in postfusion influenza hemagglutinin
- Human memory CD4+ T cells recognize non-infected macrophage bystanders exposed to Mycobacterium tuberculosis-infected cells
- Mucosal-associated invariant T cells recognize a tumor-derived metabolite in the DNA synthesis pathway
- Discoidins are cytosolic lectins that recognize methylated L-rhamnose epitopes on mycobacterial glycolipids and glycopeptidolipids upon vacuole damage
BibTeX
@misc{katte2026peptide,
title = {{Peptide inhibitors recognize prefusion viral fusion proteins with heterogeneous stoichiometry and rapid kinetics}},
author = {R. H. Katte and J. Liu and Y. He and B. Thakur and X. Huang and J. Lindenberger and W. Xu and N. K. Gonepudi and Y. Han and K. Janowska and R. J. Edwards and P. Acharya and M. Lu},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.14.750718},
url = {https://www.biorxiv.org/content/10.64898/2026.09.14.750718v1},
note = {CC BY-NC},
}
RIS
TY - UNPB
TI - Peptide inhibitors recognize prefusion viral fusion proteins with heterogeneous stoichiometry and rapid kinetics
AU - R. H. Katte
AU - J. Liu
AU - Y. He
AU - B. Thakur
AU - X. Huang
AU - J. Lindenberger
AU - W. Xu
AU - N. K. Gonepudi
AU - Y. Han
AU - K. Janowska
AU - R. J. Edwards
AU - P. Acharya
AU - M. Lu
PY - 2026
DA - 2026/09/14
PB - bioRxiv
DO - 10.64898/2026.09.14.750718
UR - https://www.biorxiv.org/content/10.64898/2026.09.14.750718v1
AB - Peptide fusion inhibitors, an important class of antivirals, block viral entry by targeting fusion proteins required for membrane fusion. However, their interactions with intact trimeric fusion proteins remain elusive; direct observation of binding on virions or native-like trimers has been lacking. Here, we developed a single-molecule imaging platform to visualize peptide binding in real time. LP-98 bound HIV-1 Envelope (Env) trimers on virions and, unexpectedly, prefusion-stabilized soluble Env trimers, with higher affinity for virion-associated Env and, among soluble trimers, a mutant Env. RSV fusion-inhibiting T-118 and 4ca similarly engaged prefusion-stabilized fusion (F) trimers with rapid kinetics and high-nanomolar affinities. Binding to prefusion Env or F demonstrates that peptide inhibitors can act earlier than the canonical prehairpin-intermediate model suggests. Individual binding events revealed heterogeneous peptide-to-trimer stoichiometries, with single-peptide occupancy predominating, while stepwise and simultaneous events revealed multiple routes to higher occupancy. These findings expand the canonical model of peptide fusion inhibition and provide previously inaccessible mechanistic insights into how antiviral peptide fusion inhibitors act.
ER -